Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JMM who wrote (5159)	8/14/1998 2:17:00 PM
From: Steve Fancy	of 6136

AGPH is very weak right now. Watch out if it breaks 23 convincingly. It's hovering on the brink of disaster...haven't really seen anything suggesting the two big news pieces of the week did anything other than further dampen enthusiasm. The Remune possibilities haven't generated an ounce of pep either. It's really not looking good. The AGPH story needs to be understood. I'm really hoping that AGPH's largest problem is their IR department. IR should be much more than giving callers technical answers and leaving folks with the warm fuzzies. I believe I saw something recently from AGPH suggesting that putting news releases together just takes too much time, something they claimed to be too short of. On the other hand, I respect the opinions of Rick and others here and am holding off from putting the first K on the block. The following statement was in a post on Yahoo...any comments? One beautiful thing about a separate stock to track the oncology pipeline, it will force shorts to run for cover no later than the effective date. If not, they have to make up the new stock to those entitled to receive it. sf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next